Cardiovascular risk stratification and management in pre-diabetes (Q38205374)

31 August 2017

title

Cardiovascular risk stratification and management in pre-diabetes (English)

1 reference

31 August 2017

Nanna Borup Johansen

0 references

Dorte Vistisen

0 references

Kristine Færch

0 references

Marit Eika Jørgensen

0 references

1 June 2014

1 reference

31 August 2017

published in

Current diabetes report

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

page(s)

493

1 reference

Diabetes mellitus, fasting glucose, and risk of cause-specific death

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prediabetes: a high-risk state for diabetes development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prevalence and control of diabetes in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Cardiovascular disease prevention in women: a rapidly evolving scenario

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Sex differences in insulin resistance and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Resear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effect of valsartan on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Predicting the 30-year risk of cardiovascular disease: the framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Pre-diabetes, metabolic syndrome, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Blood glucose may be an alternative to cholesterol in CVD risk prediction charts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

The DREAM trial – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Prevalence of Diabetes in Chinese Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0493-1

Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?

21 January 2018

1 reference

12 December 2020

Breaking up is hard to do: the heartbreak of dichotomizing continuous data.

1 reference

12 December 2020

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

12 December 2020

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

12 December 2020

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

1 reference

12 December 2020

10.1007/S11892-014-0493-1

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1030437904

0 references

Fatcat ID

release_qjcb4z5e5rhmpltsjpcfd7f3dy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qjcb4z5e5rhmpltsjpcfd7f3dy

24 November 2022

mapped directly with Wikidata item

1 reference